Press Release
Global Postoperative Pain Management Market, is segmented on the basis of pain type ( Acute Pain, Moderate Pain, Severe Pain), Product (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Antiepileptic Drugs, COX -2 Inhibitor, Opioids, Other Analgesics), Application (Cancer Pain, Arthritic Pain, Neuropathic Pain, Musculoskeletal Pain, Migraine), Target Area (Back, Legs, Hands & Arms and Others), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to gain traction over the forecast period between 2019 and 2027.
As per the report, analgesics are the one and the most important part of post-operative pain management that includes various drug classes and drug forms. Analgesics in post-operative pain can be administered through various routes as required according to the patient need and ability to respond. Analgesics are available in the form of oral tablets, oral suspensions, patches, parenteral forms and others. There are numerous types of post-operative pains for which different types of medications are prescribed. However, there are very severe pain that is mostly related to the cancer, cancer has a humongous impact on the society and it is on the high as the time flows and the pain related to this incomparable. In the U.S., around, 17.5 Lakh of the population in 2018, was diagnosed with certain type of cancer among them around 6 Lakh people died due to severe cancer symptoms. The number is burdening the American healthcare system as around 440 people per 100,000 men and women per year are being diagnosed with cancer as per the National Cancer Institute. By overviewing the epidemiology of the disease it can be expected that there will be an immense growth in the post-operative pain management market in the near future.
MMC Study identifies some of the key participating players in Postoperative Pain Management market globally are Teva Pharmaceutical Industries Ltd., Novartis AG, Allergan plc, Mylan N.V., Pfizer Inc., Purdue Pharma L.P, Janssen Pharmaceuticals, Inc., Endo International plc, Pacira Pharmaceuticals Inc., Egalet Corporation., and GlaxoSmithKline Plc. etc.
